483 New Zealand Pharmaceutical May 2018

483 New Zealand Pharmaceutical May 2018

Jose Melendez FDA$119.00 - Available Now

FDA investigators audited the New Zealand Pharmaceutical - Manawatu, Wanganui, New Zealand facility and issued inspectional observations (via FDA 483) on 25 May 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 25 May 2018
  • Location: Manawatu, Wanganui, New Zealand
  • FEI: 3003430615
Add To Cart